[English] 日本語
Yorodumi- EMDB-75233: SARS-CoV-2 spike trimer in the early fusion intermediate conforma... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | SARS-CoV-2 spike trimer in the early fusion intermediate conformation bound to the VN01H1 Fab (global refinement) | |||||||||
Map data | ||||||||||
Sample |
| |||||||||
Keywords | Virus / coronaviruses / E-FIC / ACE2 / VN01H1 Fab / Glycoprotein / Receptor / Structural Genomics / Seattle Structural Genomics Center for Infectious Disease / SSGCID | |||||||||
| Biological species | ![]() Homo sapiens (human) / SARS-CoV-2 pseudovirus | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.8 Å | |||||||||
Authors | Park YJ / Seattle Structural Genomics Center for Infectious Disease (SSGCID) / Veesler D | |||||||||
| Funding support | United States, 2 items
| |||||||||
Citation | Journal: Nat Struct Mol Biol / Year: 2026Title: TMPRSS2-mediated coronavirus spike activation and inhibition. Authors: Matthew McCallum / James Brett Case / Jack T Brown / Young-Jun Park / Jimin Lee / Emmajay Sutherland / Anupriya Aggarwal / Cecily Gibson / Florian A Lempp / Cameron Stewart / M Alejandra ...Authors: Matthew McCallum / James Brett Case / Jack T Brown / Young-Jun Park / Jimin Lee / Emmajay Sutherland / Anupriya Aggarwal / Cecily Gibson / Florian A Lempp / Cameron Stewart / M Alejandra Tortorici / Shilpa Sanapala / Jun Siong Low / Daniel Asarnow / Dana Bohan / Exequiel Dellota / Benjamin Merz / Bhavna Chawla / Swagata Kar / Antonio Lanzavecchia / Federica Sallusto / Nicholas M Riley / Stuart Turville / Lisa Purcell / Michael S Diamond / David Veesler / ![]() Abstract: The protease TMPRSS2 facilitates coronavirus infections, yet its mechanism of viral glycoprotein recognition remains unclear. Here we show that, following ACE2 engagement of the SARS-CoV-2 spike (S) ...The protease TMPRSS2 facilitates coronavirus infections, yet its mechanism of viral glycoprotein recognition remains unclear. Here we show that, following ACE2 engagement of the SARS-CoV-2 spike (S) inducing the early fusion intermediate conformation (E-FIC), TMPRSS2 cleaves the R815 S' site and promotes fusogenic conformational changes leading to viral entry. We unveil TMPRSS2 recognition of S', identify key residues modulating binding specificity and demonstrate that S' site-directed broadly neutralizing antibodies target E-FIC and inhibit viral entry by blocking TMPRSS2 access. We computationally designed stabilized E-FIC as a vaccine candidate, overcoming the transient nature of this state. We describe a TMPRSS2-directed monoclonal antibody inhibiting several coronaviruses, including SARS-CoV-2 variants and protecting mice against SARS-CoV-2 challenge. These results outline the mechanistic role of TMPRSS2 and S' site-directed antibodies in coronavirus entry. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_75233.map.gz | 203.9 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-75233-v30.xml emd-75233.xml | 22.2 KB 22.2 KB | Display Display | EMDB header |
| Images | emd_75233.png | 86.1 KB | ||
| Filedesc metadata | emd-75233.cif.gz | 6.4 KB | ||
| Others | emd_75233_additional_1.map.gz emd_75233_half_map_1.map.gz emd_75233_half_map_2.map.gz | 106.1 MB 200 MB 200 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-75233 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-75233 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 11hkC ![]() 11hlC ![]() 11hnC ![]() 11hwC ![]() 9opqC ![]() 9oprC ![]() 9yyuC ![]() 9yyvC ![]() 9z3jC ![]() 9z3kC C: citing same article ( |
|---|
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_75233.map.gz / Format: CCP4 / Size: 216 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 1.3917 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Additional map: #1
| File | emd_75233_additional_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #1
| File | emd_75233_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #2
| File | emd_75233_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : VN01H1 Fab-bound SARS-CoV-2 E-FIC
| Entire | Name: VN01H1 Fab-bound SARS-CoV-2 E-FIC |
|---|---|
| Components |
|
-Supramolecule #1: VN01H1 Fab-bound SARS-CoV-2 E-FIC
| Supramolecule | Name: VN01H1 Fab-bound SARS-CoV-2 E-FIC / type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
|---|
-Supramolecule #2: SARS-CoV-2 Spike glycoprotein
| Supramolecule | Name: SARS-CoV-2 Spike glycoprotein / type: complex / ID: 2 / Parent: 1 / Macromolecule list: #1 |
|---|---|
| Source (natural) | Organism: ![]() |
-Supramolecule #3: VN01H1 Fab
| Supramolecule | Name: VN01H1 Fab / type: complex / ID: 3 / Parent: 1 / Macromolecule list: #2-#3 |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
-Macromolecule #1: SARS-CoV-2 spike in the early fusion intermediate conformation
| Macromolecule | Name: SARS-CoV-2 spike in the early fusion intermediate conformation type: protein_or_peptide / ID: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: SARS-CoV-2 pseudovirus |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MGILPSPGMP ALLSLVSLLS VLLMGCVAET GTQCVNLTTR TQLPPAYTNS FTRGVYYPDK VFRSSVLHST QDLFLPFFSN VTWFHAIHVS GTNGTKRFDN PVLPFNDGVY FASTEKSNII RGWIFGTTLD SKTQSLLIVN NATNVVIKVC EFQFCNDPFL GVYYHKNNKS ...String: MGILPSPGMP ALLSLVSLLS VLLMGCVAET GTQCVNLTTR TQLPPAYTNS FTRGVYYPDK VFRSSVLHST QDLFLPFFSN VTWFHAIHVS GTNGTKRFDN PVLPFNDGVY FASTEKSNII RGWIFGTTLD SKTQSLLIVN NATNVVIKVC EFQFCNDPFL GVYYHKNNKS WMESEFRVYS SANNCTFEYV SQPFLMDLEG KQGNFKNLRE FVFKNIDGYF KIYSKHTPIN LVRDLPQGFS ALEPLVDLPI GINITRFQTL LALHRSYLTP GDSSSGWTAG AAAYYVGYLQ PRTFLLKYNE NGTITDAVDC ALDPLSETKC TLKSFTVEKG IYQTSNFRVQ PTESIVRFPN ITNLCPFGEV FNATRFASVY AWNRKRISNC VADYSVLYNS ASFSTFKCYG VSPTKLNDLC FTNVYADSFV IRGDEVRQIA PGQTGKIADY NYKLPDDFTG CVIAWNSNNL DSKVGGNYNY LYRLFRKSNL KPFERDISTE IYQAGSTPCN GVEGFNCYFP LQSYGFQPTN GVGYQPYRVV VLSFELLHAP ATVCGPKKST NLVKNKCVNF NFNGLTGTGV LTESNKKFLP FQQFGRDIAD TTDAVRDPQT LEILDITPCS FGGVSVITPG TNTSNQVAVL YQGVNCTEVP VAIHADQLTP TWRVYSTGSN VFQTRAGCLI GAEHVNNSYE CDIPIGAGIC ASYQTQTNSP SGARSVASQS IIAYTMSLGA ENSVAYSNNS IAIPTNFTIS VTTEILPVSM TKTSVDCTMY ICGDSTECSN LLLQYGSFCT QLNRALTGIA VEQDKNTQEV FAQVKQIYKT PPIKDFGGFN FSQILPDPSK PSKRSFIEDL LFNKVTLADA GFIKQYGDCL GDIAARDLIC AQKFNGLTVL PPLLTDEMIA QYTSALLAGT ITSGWTFGAG AALQIPFAMQ MAYRFNGIGV TQNVLYENQK LIANQFNSAI GKIQDSLSST ASALGKLQDV VNQNAQALNT LVKQLSSNFG AISSVLNDIL SRLDKVEAEV QIDRLITGRL QSLQTYVTQQ LIRAAEIRAS ANLAATKMSE CVLGQSKRVD FCGKGYHLMS FPQSAPHGVV FLHVTYVPAQ EKNFTTAPAI CHDGKAHFPR EGVFVSNGTH WFVTQRNFYE PQIITTDNTF VSGNCDVVIG IVNNTVYDPL QPELDSFKEE LDKYFKNHTS PDVDLGDISG INASVVNIQK EIDRLNEVAK NLNESLIDLQ ELGKYEQYIK GSGRENLYFQ GGGGSGYIPE APRDGQAYVR KDGEWVLLST FLGHHHHHHH H |
-Macromolecule #2: Heavy chain of VN01H1 Fab
| Macromolecule | Name: Heavy chain of VN01H1 Fab / type: protein_or_peptide / ID: 2 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: EVQLVESGGG LVLPGGSLRL SCSASGFTFS DFSMHWVRQS PGKGLEYVSA ITSSGSSTYY PDSVKGRFTI SRDNSKNTLY LQMGSLRVED TAVYWCVKNS DVFRFPHLYF DVWGRGTLVT VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT ...String: EVQLVESGGG LVLPGGSLRL SCSASGFTFS DFSMHWVRQS PGKGLEYVSA ITSSGSSTYY PDSVKGRFTI SRDNSKNTLY LQMGSLRVED TAVYWCVKNS DVFRFPHLYF DVWGRGTLVT VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKR VEPKSC |
-Macromolecule #3: Light chain of VN01H1 Fab
| Macromolecule | Name: Light chain of VN01H1 Fab / type: protein_or_peptide / ID: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: DIVMTQSPAT LSVSPGDRAT LSCRASQSVS SNLAWYQQKP GQAPRLLIYG ASTRAAGIPA RFSGSGSGTE FTLTISSLQS EDFAVYYCQQ YDNWPSITFG QGTRLEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK ...String: DIVMTQSPAT LSVSPGDRAT LSCRASQSVS SNLAWYQQKP GQAPRLLIYG ASTRAAGIPA RFSGSGSGTE FTLTISSLQS EDFAVYYCQQ YDNWPSITFG QGTRLEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Buffer | pH: 7 |
|---|---|
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 60.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 3.0 µm / Nominal defocus min: 0.2 µm |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Homo sapiens (human)
Authors
United States, 2 items
Citation























Z (Sec.)
Y (Row.)
X (Col.)












































Processing
FIELD EMISSION GUN
